|
|
|
|
pmid:
|
|
|
|
|
pmid:3360596
|
|
|
|
|
pmid:9870780
|
Pastores SM et al. |
Posttraumatic multiple-organ dysfunction syndrome: role of mediators in systemic inflammation and subsequent organ failure. |
1996 |
Acad Emerg Med |
pmid:8727633
|
Goldring WP and Pattenden G |
The phomactins. A novel group of terpenoid platelet activating factor antagonists related biogenetically to the taxanes. |
2006 |
Acc. Chem. Res. |
pmid:16700534
|
Yamada T et al. |
Effects of inhaled nitric oxide on platelet-activating factor-induced pulmonary hypertension in dogs. |
1998 |
Acta Anaesthesiol Scand |
pmid:9542566
|
Nathan N et al. |
Variations in blood platelet-activating-factor levels after protamine reversal of heparin in humans. |
1992 |
Acta Anaesthesiol Scand |
pmid:1574976
|
Sipka S et al. |
Atropine is an inhibitor of the chemiluminescence induced by platelet-activating factor in human neutrophils. |
1987 |
Acta Biochim. Biophys. Hung. |
pmid:3132002
|
Ren J et al. |
Protective effect of dexmedetomidine against myocardial ischemia-reperfusion injury in rabbits. |
2018 |
Acta Cir Bras |
pmid:29412230
|
Peterson JR et al. |
Platelet activating factor antagonist design. 3. X-ray crystal structure and intermolecular crystal lattice interactions of methyl trans-4-acetoxymethyl-4,5-dihydro-2,5-bis(3,4-methylenedioxyphenyl)- 3-furancarboxylate. |
1989 |
Acta Crystallogr C |
pmid:2604943
|
Peterson JR et al. |
Platelet activating factor antagonist design: structure of methyl trans-5-(3,4-dimethoxyphenyl)-2,3,4,5-tetrahydro-2-oxo-4- furancarboxylate. |
1989 |
Acta Crystallogr C |
pmid:2610971
|
Peterson JR et al. |
Platelet activating factor antagonist design. 2. X-ray structure of dimethyl 2,3,4,5-tetrahydro-5 beta-(3,4-methylenedioxyphenyl)-2-oxo-3 beta-(3,4,5-trimethoxybenzoyl)-3 alpha,4 alpha-furandicarboxylate. |
1989 |
Acta Crystallogr C |
pmid:2610989
|
Stensland JB et al. |
Platelet activating factor antagonists. Structure of N,N'-bis(3,4,5-trimethoxybenzoyl)-2-piperazinylmethyl 2,2-dimethylpropanoate. |
1991 |
Acta Crystallogr C |
pmid:1930821
|
Juhlin L and Pihl-Lundin I |
Effects of antihistamines on cutaneous reactions and influx of eosinophils after local injection of PAF, kallikrein, compound 48/80 and histamine in patients with chronic urticaria and healthy subjects. |
1992 |
Acta Derm. Venereol. |
pmid:1357858
|
Juhlin L and Rihoux JP |
Effect of cetirizine on cutaneous reactions to PAF, kallikrein and serum in patients with chronic urticaria. |
1990 |
Acta Derm. Venereol. |
pmid:1969202
|
Fjellner B and Hägermark O |
Experimental pruritus evoked by platelet activating factor (PAF-acether) in human skin. |
1985 |
Acta Derm. Venereol. |
pmid:2416164
|
Abramovici Y et al. |
Control of the proliferation and differentiation of GEJ under platelet aggregating factor treatment. |
1987 |
Acta Endocrinol Suppl (Copenh) |
pmid:3475908
|
Plachot M |
Markers for establishing the adequacy of embryonal development in assisted conception. |
1993 Sep-Oct |
Acta Eur. Fertil. |
pmid:7985464
|
Aderka D et al. |
Morphological platelet anomalies in thrombotic thrombocytopenic purpura. |
1982 |
Acta Haematol. |
pmid:6801893
|
Bussolino F et al. |
Platelet-activating factor--a powerful lipid autacoid possibly involved in microangiopathy. |
1986 |
Acta Haematol. |
pmid:3019063
|